In a wide variety of cancers–including hematogenous malignancies (such as leukemia, lymphoma, and multiple myeloma), and solid tumors (such as lung, breast and pancreas)–NF-κB is persistently activated [8], [9]. The gene discussed is NFKB1; the disease is plasma cell myeloma.